Aberdeen Group’s Cidara Therapeutics CDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.7M Buy
259,916
+139,037
+115% +$6.77M 0.02% 542
2025
Q1
$2.6M Buy
+120,879
New +$2.6M 0.01% 741